Intco Medical Technology 英科医疗
21 significant filings since 29 May 2026: 13 on guarantee or financial assistance, 3 on pledge released and 3 on dividend, and 1 other kind. The latest, on 15 Sep 2026: 关于为子公司提供担保事项的进展公告.
自 29 May 2026 起有 21 份重大公告：guarantee or financial assistance 13 份、pledge released 3 份、dividend 3 份，另有 1 类。最新一份（15 Sep 2026）：关于为子公司提供担保事项的进展公告。
The tick on each bar marks the whole market, where 99.3% of rated reports in the same twelve months said Buy or Outperform. 刻度线为全市场水平：同期 99.3% 的评级为买入或跑赢。 Every rated report on this company said Buy or Outperform.
No broker has changed its rating on this company in the reports held.
| Broker 券商 | Analyst 分析师 | Latest Rating 最新评级 | Date 日期 | Reports 研报 | Target 目标价 |
|---|---|---|---|---|---|
| 国信证券 | 陈曦炳,彭思宇,张超,凌珑 | Outperform 增持 | 1 Sep 2026 | 3 | — |
| 信达证券 | 姜文镪,李晨 | Unrated | 30 Aug 2026 | 1 | — |
| 西南证券 | 杜向阳,雷瑞 | Unrated | 27 Aug 2026 | 1 | — |
| 开源证券 | 余汝意,陈峻,石启正 | Buy 买入 | 26 Aug 2026 | 2 | — |
| 国金证券 | 毕先磊,赵中平 | Buy 买入 | 25 Aug 2026 | 2 | — |
| 华安证券 | 谭国超,李婵 | Buy 买入 | 26 Dec 2025 | 1 | — |
| 中邮证券 | 盛丽华,陈峻 | Buy 买入 | 11 Nov 2025 | 1 | — |
Each row is a broker's latest report in the last twelve months. A price target is given in 1 of 11 reports. 每行为该券商近十二个月的最新研报；11 份中 1 份给出目标价。
Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数，最近一个季度尚未结束。